Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP650551.RAsVX971tkaqmAPfqZmqStLeyM9C6_zO1Rjrn-w9V6Z9Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP650551.RAsVX971tkaqmAPfqZmqStLeyM9C6_zO1Rjrn-w9V6Z9Y130_assertion type Assertion NP650551.RAsVX971tkaqmAPfqZmqStLeyM9C6_zO1Rjrn-w9V6Z9Y130_head.
- NP650551.RAsVX971tkaqmAPfqZmqStLeyM9C6_zO1Rjrn-w9V6Z9Y130_assertion description "[In conclusion, high level amplification of HER-2/neu or EGFR is infrequent in endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650551.RAsVX971tkaqmAPfqZmqStLeyM9C6_zO1Rjrn-w9V6Z9Y130_provenance.
- NP650551.RAsVX971tkaqmAPfqZmqStLeyM9C6_zO1Rjrn-w9V6Z9Y130_assertion evidence source_evidence_literature NP650551.RAsVX971tkaqmAPfqZmqStLeyM9C6_zO1Rjrn-w9V6Z9Y130_provenance.
- NP650551.RAsVX971tkaqmAPfqZmqStLeyM9C6_zO1Rjrn-w9V6Z9Y130_assertion SIO_000772 18202752 NP650551.RAsVX971tkaqmAPfqZmqStLeyM9C6_zO1Rjrn-w9V6Z9Y130_provenance.
- NP650551.RAsVX971tkaqmAPfqZmqStLeyM9C6_zO1Rjrn-w9V6Z9Y130_assertion wasDerivedFrom befree-2016 NP650551.RAsVX971tkaqmAPfqZmqStLeyM9C6_zO1Rjrn-w9V6Z9Y130_provenance.
- NP650551.RAsVX971tkaqmAPfqZmqStLeyM9C6_zO1Rjrn-w9V6Z9Y130_assertion wasGeneratedBy ECO_0000203 NP650551.RAsVX971tkaqmAPfqZmqStLeyM9C6_zO1Rjrn-w9V6Z9Y130_provenance.